Opisthorchiasis caused by Opisthorchis viverrini induces periductal fibrosis via host immune/inflammatory responses. Plasma protein alteration during host-parasite interaction-mediated inflammation may provide potential diagnostic and/or prognostic biomarkers. To search for target protein changes in O. viverrini-infected hamsters, a 1-D PAGE gel band was trypsin-digested and analyzed by a LC-MS/MS-based proteomics approach in the plasma profile of infected hamsters, and applied to humans. Sixty seven proteins were selected for further analysis based on at least two unique tryptic peptides with protein ID score >10 and increased expression at least two times across time points. These proteins have not been previously identified in O. viverrini-associated infection. Among those, proteins involved in structural (19%), immune response (13%), cell cycle (10%) and transcription (10%) were highly expressed. Western blots revealed an expression level of protein tyrosine phosphatase alpha (PTPα) which reached a peak at 1 month and subsequently tended to decrease. Fibronectin significantly increased at 1 month and tended to increase with time, supporting proteomic analysis. PTPα was expressed in the cytoplasm of inflammatory cells, while fibronectin was observed mainly in the cytoplasm of fibroblasts and the extracellular matrix at periductal fibrosis areas. In addition, these protein levels significantly increased in the plasma of O. viverrini-infected patients compared to healthy individuals, and significantly decreased at 2-months post-treatment, indicating their potential as disease markers. In conclusion, our results suggest that plasma PTPα and fibronectin may be associated with opisthorchiasis and the hamster model provides the basis for development of novel diagnostic markers in the future.
Citation: Khoontawad J, Laothong U, Roytrakul S, Pinlaor P, Mulvenna J, Wongkham C, et al. (2012) Proteomic Identification of Plasma Protein Tyrosine Phosphatase Alpha and Fibronectin Associated with Liver Fluke, Opisthorchis viverrini, Infection. PLoS ONE 7(9): e45460. https://doi.org/10.1371/journal.pone.0045460
Editor: Patricia Talamas-Rohana, Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional, Mexico
Received: May 24, 2012; Accepted: August 22, 2012; Published: September 18, 2012
Copyright: © Khoontawad et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by Thailand Research Fund through Royal Golden Jubilee Ph.D. Program (to JK and SP); Thailand Research Fund (RMU5380016); Research Team Strengthening Grant from BIOTEC-NSTDA, Thailand; The Higher Education Research Promotion and National Research University Project of Thailand; and Office of the Higher Education Commission, through the Health Cluster (SHeP-GMS), Khon Kaen University, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Opisthorchiasis caused by infection with the liver fluke Opisthorchis viverrini remains a major health problem in large parts of Southeast Asia, including Thailand, Lao PDR, Vietnam and Cambodia. Currently, more than 600 million people are estimated to be at risk of infection . Chronic infection with O. viverrini is a risk factor for cholangiocarcinoma (CCA), cancer of the bile duct, which is thought to develop as a consequence of chronic inflammation , . There is no stronger association between an eukaryotic pathogen and cancer than that between O. viverrini and CCA in northeast Thailand, where infection is endemic, and rates of CCA are unprecedented .
In acute O. viverrini infections the major histopathological changes include the accumulation of inflammatory cells, nitric oxide (NO)-mediated DNA damage and liver tissue injury . This makes diagnosis of O. viverrini infection difficult as these changes are clinically silent and generally only detected after ultrasound imaging in severe cases of chronic infection . Thickening of periductal fibrosis is the most prominent histopathological finding after long-term infection and is found in both opisthorchiasis patients  and O. viverrini-infected hamsters . Moreover, periductal fibrosis increases in hamsters with CCA induced by a combination of O. viverrini infection and the administration of a carcinogen (nitrosamine) . Thus, the relationship between periductal fibrosis and CCA suggests that expression changes in biomolecules involved in inflammation, such as those provoked by DNA damage , etheno DNA adducts  and other fibrotic markers could be used as prognostic marker of opisthorchiasis-associated CCA in humans. Moreover, plasma contains all tissue proteins leakage , which may serve as protein-disease markers discovery.
In this study, a proteomics technique was used to search for all possible target protein-disease associations in a hamster model and these were then applied to human subjects. To find target plasma protein changes in O. viverrini-infected hamsters, plasma protein was separated using 1-D PAGE, and identified using LC-MS/MS after in-gel tryptic digestion. MS analysis revealed significant changes in the structural protein, fibronectin, and the signal transduction protein, protein tyrosine phosphatase (PTP). These changes were confirmed by western blotting and immunohistochemistry. These two candidate markers were also found to be increased in the plasma of human opisthorchiasis patients and to be decreased after praziquantel treatment. Therefore, plasma proteome of the hamster model is able to provide potential diagnostic biomarkers for opisthorchiasis in humans that could be developed as diagnostic tools for the early detection of opisthorchiasis and, consequently, can act as relative risk factors for O. viverrini-induced CCA.
Materials and Methods
Opisthorchis viverrini metacercariae were isolated from naturally infected cyprinid fish by pepsin digestion as described previously . Recently caught and dead cyprinid fish, chilled on ice, were obtained from markets in Khon Kaen Province, Thailand. The fish were digested in 0.25% pepsin-HCl and O. viverrini metacercariae were isolated and counted. Viable cysts were used for hamster infection.
Animals and experimental design
The Animal Ethics Committee of Khon Kaen University approved this study under permit number AEKKU 17/2552. Experiments in an animal model used in this study were conducted and performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Research Council of Thailand. All experimental protocols were approved by the Institutional Animal Ethics Committee, Khon Kaen University and the National Research Council of Thailand for use of laboratory animals. All surgery and necropsy was performed under ether anesthesia, and every effort was made to minimize pain and suffering to the animals.
Male syrian golden hamsters (Mesocricetus auratus) (obtained from the Animal Unit, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand) aged between 4–6 weeks were used in this study. Hamsters were housed under conventional conditions, fed a stock murine diet (CP-SWT, Thailand), and were given water ad libitum. Seventy animals were divided into infected and un-infected groups. In the infected group, animals were infected with 50 metacercariae of O. viverrini by intragastric inoculation and were sacrificed at day 21 and 1, 2, 3, 4, 5, and 6 month(s) post-infection, and five animals were included in each subgroups. A normal animal underwent the same procedure as the infected group, minus the metacercariae, and was used as a control.
Animals were anaesthetized with ether and blood was collected from the heart. To improve resolution, sensitivity and reproducibility of peptide identifications, we used platelet-depleted plasma samples. For this purpose, ethylenediamine tetra-acetate (EDTA)-blood samples were kept in an ice-box for 2–3 h before centrifugation. Next, they were centrifuged at 3,000×g for 10 min at 4°C and the plasma was stored at −80°C until analysis. Hemolysed samples were excluded in this study –. The hilar region and adjacent areas of the liver were dissected and tissues were placed in 10% buffered formalin. After fixation overnight, they were processed in a conventional manner. Tissue sections (5- µm thickness) were stained with hematoxylin and eosin to evaluate histopathologic changes and used for immunohistochemical study.
Patient and study design
Written informed consent was obtained from 57 volunteers including healthy individuals (n = 18), and patients with O. viverrini infection (n = 39, matched pre- and post-treatment). Subjects in each group were selected on the basis of age- and sex-matched control. O. viverrini-infected patients from endemic areas in Khon Kaen Province, Thailand, were examined for parasite eggs in stools by formalin ethyl acetate concentration technique . Periductal fibrosis in opisthorchiasis patient was graded by ultrasonography. The grading score was defined as follows: grade 0 when no echoes were observed; 1+ when echoes were observed in one segment of the liver; and 2+ when echoes were observed in two or three segments of the liver as described previously . Plasma of opisthorchiasis subjects was collected either before or at 2 months post praziquantel treatment. Healthy individuals were confirmed as such by the absence of O. viverrini eggs in stool, normal urinary analysis, and normal hepatobiliary tract as evaluated by ultrasonography. Acute infected patients showing positive for nitrate/nitrite and leukocyte in urine were omitted; patients with chronic inflammatory conditions due to hepatitis B virus and TB infections and those with diabetes mellitus were excluded. In addition, among the control candidates, one who had a history of those diseases before 6 months of investigation was excluded. The hemolysed peripheral blood samples were also excluded for measurements. The study protocol was approved by the Khon Kaen University Ethics Committee for Human Research (HE531174).
Peripheral 10 ml blood samples were obtained by sterilized venipuncture, collected in tubes containing heparin and centrifuged at 3000×g for 15 min at 4°C. Plasma was then isolated and stored at −80°C until analysis.
Workflow of the study
Figure 1 shows the workflow used to search for alterations in protein expression associated with O. viverrini-infected hamsters, and to validate these proteins as potential diagnostic and prognostic biomarkers. Briefly, normal and O. viverrini-infected hamster plasma from different time points was fractionated using SDS-PAGE. Next, the gel was silver stained (Figure 2). Gel bands above (in 7.5% gel) and below (in 12.5% gel) albumin band (approximately 76 kDa) were cut, and the resulting proteins were used in LC-MS/MS analysis after in-gel tryptic digestion. Candidate protein markers were validated in hamster plasma and liver sections by western blot and immunohistochemistry. To assess the utility of these animal markers in human subjects, these markers were validated in opisthorchiasis patients using western blot analysis.
After fish digestion, O. viverrini metacercariae were collected and fed to hamsters. Animals were sacrificed on day 21, and monthly for 6 months. Pooled plasma samples obtained from five hamsters in each time point were fractionated by SDS-PAGE. Then, entire lanes were excised into slices, digested by trypsin, and were analyzed by LC-MS/MS. After database searching and data analysis, candidate proteins were further validated by western blot and immunohistochemistry. In addition, to apply into human, expression levels of these two candidate markers were also evaluated in the plasma by western blot analysis.
Fifty micrograms of pooled plasma protein obtained from 5 animals of each experimental time point was fractionated on a 7.5% and 12.5% acrylamide gel (8×13 cm). Pooled plasma was run on the gel and subsequently stained with silver staining. The each gel lane was sliced and then subjected to in-gel digestion prior to LC/MS analysis. For consistency of results, the assay was done as three independent experiments. Molecular weights of protein marker bands are indicated in kDa on the right of the images. D, days; M, month(s); OV, Opisthorchis viverrini.
Electrophoresis and tryptic digestion
Plasma protein concentration was measured by Lowrys' method . An equal amount of plasma protein from 5 animals at each time-point of the infected and uninfected groups was pooled. Infected and uninfected plasma protein samples (50 µg each) from each time point were fractionated on both 7.5% and 12.5% polyacrylamide gels (8×13 cm). After silver staining, the bands above albumin in 7.5% gel and below albumin band in 12.5% gel were sliced into 15–18 pieces per lane. Each gel slice was cut into 1 mm pieces, and depending on the size of each slice, approximately 70–90 pieces were digested by trypsin. The gel pieces were subjected to in-gel digestion using an in-house method developed by Proteomics Laboratory, Genome Institute, National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), Thailand. Briefly, the gel slices were dehydrated with 100% acetonitrile (ACN), reduced with 10 mM DTT in 10 mM ammonium bicarbonate at room temperature for 1 h and alkylated at room temperature for 1 h in the dark in the presence of 100 mM iodoacetamide (IAA) in 10 mM ammonium bicarbonate. After alkylation, the gel pieces were dehydrated twice with 100% ACN for 5 min. To perform in-gel digestion of proteins, 10 µl of trypsin solution (10 ng/ µl trypsin in 50% ACN/10 mM ammonium bicarbonate) was added to the gels, followed by incubation at room temperature for 20 min. To keep the gels immersed throughout digestion, 20 µl of 30% ACN was added and incubated at 37°C for overnight. To extract peptide digestion products, 30 µl of 50% ACN in 0.1% formic acid was added into the gels and incubated at room temperature for 10 min in a shaker. Peptides extracted were collected, dried by vacuum centrifuge and kept at −80°C for further mass spectrometric analysis.
HCTultra LC-MS/MS analysis
Peptide solutions were analyzed using a HCTultra PTM Discovery System (Bruker Daltonics Ltd., U.K.) coupled to an UltiMate 3000 LC System (Dionex Ltd., U.K.). Peptides were separated on a nanocolumn (PepSwift monolithic column 100 µm i.d.×50 mm). Eluent A was 0.1% formic acid and eluent B was 80% acetonitrile in water containing 0.1% formic acid. Peptide separation was achieved with a linear gradient from 10% to 70% B for 13 min at a flow rate of 300 nl/min, including a regeneration step at 90% B and an equilibration step at 10% B, one run took 20 min. Peptide fragment mass spectra was acquired in data-dependent AutoMS (2) mode with a scan range of 300–1500 m/z, 3 averages, and up to 5 precursor ions selected from the MS scan 50–3000 m/z.
Protein quantitation and identification
For protein quantitation, DeCyder MS Differential Analysis software (DeCyderMS, GE Healthcare)  was used. Acquired LC-MS raw data was converted to mzXML format using CompassXport and the PepDetect module was used for automated peptide detection, charge state assignments, and quantification based on the peptide ions signal intensities in MS mode. The analyzed MS/MS data from DeCyderMS was submitted to database searching using the MASCOT software version 2.2 (Matrix Science, London, UK). The data were searched against the NCBI database for protein identification. Search parameters were as follows: Trypsin was selected as the enzyme, with three potential missed cleavage, carbamidomethylated cysteine as fixed modification and oxidation of methionine residues as a variable modification. Peptide mass tolerance was 1.2 Da, fragment mass tolerance was 0.6 Da. ESI ion trap was selected for the instrument type. Identified protein with at least 2 peptides from MASCOT was accepted to be a true match. Over-expressed proteins at least two times across time points and protein ID score > 10 was used as the criterion. The MultiExperiment Viewer (MeV, version 4.6.1) software was used to show maps of protein levels corresponding to the sequences of over-expressed protein profile in O. viverrini-infected hamsters in Table 1. The molecular function and biological process was assigned to the protein identified according to the Uniprot database (http://www.uniprot.org).
Western blot analysis
To validate candidate marker proteins, twenty micrograms of plasma protein was separated on a SDS-PAGE and transferred to a polyvinylidene difluoride membrane (PVDF, Amersham Bioscience, Piscataway, NJ, USA) for 2 h at 60 V. The membrane was blocked with 5% nonfat dried milk powder in phosphate-buffer saline with 0.1%Tween−20 (PBS-T, pH 7.5) for 1 h at room temperature, and then incubated overnight at 4°C with rabbit polyclonal anti-fibronectin or rabbit polyclonal anti-PTPα antibodies diluted in 2% nonfat dried milk-PBS-T (each 1∶3000, ab2413 and ab77792, Abcam, Cambridge, U.K, respectively). After washing with 0.1% PBS-T, the membrane was incubated for 1 h at room temperature with a 1∶3,000 dilution of horseradish peroxidase (HRP)-conjugated secondary antibody (GE Healthcare) diluted in 2% nonfat dried milk/PBS-T. The immunoreactive material was visualized by enhanced chemiluminescence using ECL Western blotting Detection Reagent (GE Healthcare). The intensity of bands of O. viverrini infected group was compared to that of un-infected control at the same time points post-treatment. Relative band intensity was compared by using ImageQuant TL software v2005 (126.96.36.199) (non-linear Dynamics, Durham, NC).
Histopathological study and immunohistochemical staining
The liver tissues were deparaffinized in xylene and then hydrated through a graded series from ethanol to water. For antigen retrieval, sections were floated on 10 mM citric acid buffer (pH 6.0) and then heated at 95–100°C for 10 min and left to stand for 30 min at room temperature. The heat-treated sections were washed twice for 5 min each with PBS (pH 7.4). Before staining, endogenous peroxidase activity was eliminated by incubation for 15 min in 3% hydrogen peroxide in PBS. After washing in PBS, specimens were blocked with 5% fetal bovine serum (Invitrogen, New York, America) for 30 min at room temperature and then incubated overnight at 4°C with 1∶200 rabbit polyclonal anti-fibronectin or 1∶100 rabbit polyclonal anti-PTPα antibodies diluted in PBS (ab2413 and ab77792, Abcam, Cambridge, U.K., respectively). After washing with PBS, the sections were incubated for 1 h at room temperature with horseradish peroxidase-conjugated goat anti-rabbit IgG antibody (1∶200, GE Healthcare). After washing in PBS, stained sections were visualized with 3,3-diaminobenzidine tetrahydrochloride as a chromogen for approximately 5 min. The sections were washed in distilled water and counterstained with hematoxylin for 1 min.
The degree of PTPα and fibronectin expression was evaluated independently by three investigators and were scored as the expression index, in that the percentage of positively stained of inflammatory cells and fibroblasts in the extracellular matrix of periductal fibrosis at 400× magnification (10 randomly selected fields) was calculated and graded according to the scores; grade 0, <30%; grade 1, 30–70% and grade 2, >70% of liver tissues areas .
The data were expressed as mean ± S.D. To compare the expression level of protein in infected group compare with normal group, statistical significance of bands intensity was determined using student's t-test. A non-parametric Mann-Whitney U test was used to compare the grading score of fibronectin and PTPα. Statistical analyses were performed using SPSS version 11.5. P values less than 0.05 were considered statistically significant.
Plasma proteomics analysis
Proteins extracted from pooled plasma samples of normal and O. viverrini-infected groups were resolved by SDS-PAGE on 7.5% and 12.5% polyacrylamide gels (Figure 2). Each gel slice was independently subjected to in gel tryptic digestion and the resulting peptides were analyzed by LC-MS/MS. A total of 2,957 non-redundant protein identifications were made from 50 µg of protein. To find candidate proteins for biomarker discovery, we focused on over-expressed proteins. Sixty seven proteins were selected for further analysis based on at least two unique tryptic peptides with protein ID score >10 and increased expression at least two times across time points. The alteration of enriched proteins of time in O. viverrini-infected hamsters compared to control was shown using MultiExperiment Viewer (MeV, version 4.6.1) software (Figure 3). Details of the 67 proteins and their biological function are presented in Table 1. Highly abundant proteins, with more than 20 peptide matches, included i.e., CLC-7 chloride channel protein, E3 ubiquitin-protein ligase RNF123, glycosyltransferase and fibrinogen gamma chain. These proteins fell into broad functional categories including structural, immune system etc. Among the 67 over-expressed proteins, fibronectin had the highest protein ID score.
An over expression pattern of 67 proteins was performed with MultiExperiment Viewer (MeV, version 4.6.1) software. All quantitative information is marked using a color scale ranging from green, dark and red for no changes, a little, and the highest up-regulation ratio, respectively, in expression pattern of OV-infected compare to the normal group at 21 D, 1 M, 2 M, 3 M, 4 M, 5 M, and 6 M post-infection. D, days; M, month(s); OV, Opisthorchis viverrini.
Distribution of biological function of over-expressed proteins
The 67 over-expressed proteins were classified according to their biological functions (Figure 4). The majority of assigned functions of over-expressed proteins were structural (19%), immune response (13%), cell cycle (10%), and transcription (10%). Other functions included signal transduction (9%), metabolism (9%), transport (9%), translation (4%), proteolysis (3%), biotin biosynthesis (2%), blood coagulation (2%), stress response (2%), tumor suppressor (2%), and unknown function (6%).
Validation of protein expression in hamster plasma specimens by western blot analysis
Based on the assigned functions, protein score and the pattern of overexpression, fibronectin and protein tyrosine phosphatase (PTP) proteins were selected for validation in the plasma of O. viverrini-infected hamsters and normal control groups by western blot analysis. Since protein tyrosine phosphatase alpha (PTPα) belongs to human PTP family, and based on the commercial antibody reactivity for both rodent and human proteins, we verified PTPα instead of PTP. PTPα showed a time course of over-expression in plasma that was mirrored in proteomic analysis. As in proteomics analysis, a significant increase was observed at 21 days, expression reached a peak at 1 month and then decreased from 2 months onwards (Figure 5A and 5B). Similarly, expression of fibronectin, assessed using western blotting, matched the proteomic analysis with an over-expression beginning at 1 month and increasing over all time points afterward (Figure 5A and 5C). In addition, the expression of PTPα in uninfected hamsters did not increase over time. No statistically significant increase in fibronectin level was observed at any time point in uninfected control hamsters.
Western blot was used to confirm an expression of PTPα and fibronectin (A) protein in the plasma of OV-infected group compared to normal hamsters. Independent experiments were performed for all hamsters (n = 5). Consistent results from at least 3 animals were accepted, and only one gel obtained from one hamster is shown as representative of each group. The number below gel represents relative band intensity, and the relative expression level of PTPα (B) and fibronectin (C) is shown. Immunohistochemical staining shows an expression of PTPα and fibronectin protein in the liver of OV-infected group at 1M, 3M and 6M compared to the normal group at 3M (D). One hamster liver section is representative for five animals in each experimental group. All pictures were taken with same magnification (original 400x). D, days; M, month(s); OV, Opisthorchis viverrini.
Validation of protein expression in the hamsters liver tissue specimens by immunohistochemistry
To detect the expression of fibronectin and PTPα proteins in hamster liver, immunohistochemistry was used to validate the distribution expression in tissue sections. These proteins, from the structural and signal transduction groupings, have possible roles in the accumulation of periductal fibrosis. Using specific antibody to fibronectin and PTPα, the expression of PTPα was observed mainly in the cytoplasm of inflammatory cells while fibronectin was observed mainly in the cytoplasm of fibroblasts, the extracellular matrix and some large inflammatory cells (macrophage-like cell) in periductal fibrosis areas. Compared to the normal control, the expression of PTPα significantly increased at 21 days, reached the maximal level at 1 month (grading score 2.00±0.01, P<0.05) and then decreased at 3 and 6 months post-infection (each, grading score 1.33±0.58, P<0.05). Significantly increased expression of fibronection was observed at 1 month (grading score 0.80±0.01, P<0.05) and expression continued to increase over 3 months (grading score 1.40±0.55, P<0.05) and 6 months post-infection (grading score 2.00±0.01, P<0.01). In addition, slight staining of these markers was found at the portal triad area at the base of the arteriole and bile duct in the normal liver (Figure 5D).
Characteristics of the human subjects
Plasma samples were collected from healthy volunteers (n = 18), and positive for O. viverrini-eggs (n = 39; male = 21 and female = 18). The ultrasonography revealed that the grading scores for 0, 1+, 2+ were 20, 16 and 3 patients, respectively.
Fibronectin and PTPα as the markers of human opisthorchiasis
To assess the utility of fibronectin and PTPα as biomarkers in human subjects, western blotting was used to evaluate expression levels of these proteins in plasma from infected humans. Additionally, expression levels were assessed in infected individuals before and 2 months post-treatment with praziquantel. In O. viverrini infection, the intensity of fibronectin (average 3.45±1.15 vs 1.86±0.51, P<0.05) and PTPα (average 1.28±0.18 vs 1.05±0.02, P<0.05) expression levels were significantly higher than in uninfected individuals. However, expression of these markers was not different among hepatobiliary status (grading scores 0, 1+, and 2+) (Figure 6A). In hepatobiliary grading score 1+, the expression level of PTPα (n = 12, 1.25±0.33 vs 0.91±0.34, P = 0.0001) and fibronectin (n = 12, 6.56±1.03 vs 3.78±1.45, P< 0.0001) were significantly decreased by praziquantel treatment (Figure 6B and 6C).
Equal protein was subjected to SDS-PAGE followed by immunoblotting using antibody against to PTPα and fibronectin proteins. Densitometry values are shown below of each band. Duplicate independent experiment was performed. (A) Three representative plasma samples of OV-infected patients with difference grading score (grade 0, 1+, and 2+) of periductal fibrosis evaluated by ultrasonography is presented in comparison with normal biliary system. (B) Twelve representative plasma samples of OV-infected patients with grading score 1+ shows between pre- and at 2 months post-treatment. (C) Relative bands intensity of PTPα and fibronectin in 12 OV-infected patients between pre- and post-treatment. The data are shown as mean ± S.D using pair t-test. OV, Opisthorchis viverrini.
Proteomics analysis is a powerful tool not only for the identification of diagnostic markers of disease, but also for staging of parasitic disease progression . In this study, we have utilized proteomic techniques to search for candidate markers of host protein associated with opisthorchiasis. To do so we first studied the plasma proteome of hamsters infected with O. viverrini and consequently validated in the opisthorchiasis patients. Sixty seven proteins were identified as over-expressed at least two times across time points. The major class of over-expressed protein was that possessing a structural function, although inflammatory proteins were also highly represented. Two of the over-expressed proteins, PTPα and fibronectin, were consequently confirmed as over-expressed in both experimental and human opisthorchiasis compared to uninfected controls using western blotting. Moreover, expression of these proteins significantly decreased in infected humans after praziquantel treatment. Therefore, these two proteins may have a biological role in opisthorchiasis and might serve as diagnostic markers of O. viverrini infection.
Structural proteins were the most frequently over-expressed proteins in the plasma of O. viverrini-infected hamsters. This supports previous observations that, in hamsters, periductal fibrosis increases over time , and also increases in hamsters with CCA induced by the combination of O. viverrini infection and N-nitrosodimethylamine administration . Furthermore, in humans, advanced periductal fibrosis, evaluated by ultrasonography, is currently the most powerful tool for diagnosing opisthorchiasis . On the basis of the protein score fibronectin appeared to one of structural proteins identified, but, other over-expressed structural proteins, involved in the extracellular matrix, were also identified. These included the MORN repeat-containing protein 4, developmental pluripotency associated 4, a-kinase anchor protein 11, nesprin 1, cadherin 5, kinesin-like protein KIFC2, collagen alpha-1(III) chain, protocadherin gamma B1, formin-like protein 1, kinesin-like protein KIF26B, protocadherin beta 3 and integrin alpha 7. These proteins may be associated with opisthorchiasis and, in particular, the structural changes associated with periductal fibrosis. Previously, we have identified actin, a structural protein, in hamsters liver infected with O. viverrini , but this protein was not detected in this study, possibly due to different source and technique used and actin depolymerization in plasma  of opisthorchiasis.
From the structural proteins over-expressed in O. viverrini infected hamsters, fibronectin, one of the main components of the extracellular matrix (ECM), was selected for further validation in the plasma and liver. Fibronectin is a large ECM glycoprotein that exists as a dimer and is one of the first ECM proteins to undergo up-regulation during liver fibrosis . Fibronectin is expressed in numerous cell types, including myofibroblast, and can exist in a soluble form present in plasma and various body fluids or as a cellular fibronectin that is confined to tissues . Fibronectin is also expressed by inflammatory cells in response to cytokines and/or growth factors such as TGF-β  and, previously, we have demonstrated that expression of TGF-β gene is associated with the accumulation of fibrosis in the hamster model . In the current study, increasing levels of fibronectin were observed over time in the cytoplasm of fibroblasts, the ECM and macrophage-like cells in the areas of periductal fibrosis, and these increases were also detectable in the plasma. Interestingly, fibronectin levels were reduced by praziquantel treatment, suggesting that it may serve as a diagnostic marker for the chronic bile duct disease induced by liver fluke infection, as well as for other chronic hepatic diseases .
As a general marker, it has been noted that the circulating levels of cellular fibronectin become elevated during injury or disease  and, given the injury and fibrosis caused by adult worms, it is not surprising that a similar mechanism is operating during O. viverrini infection. As a marker for parasitic infection, fibronectin was the only early stage marker of granulomatous formation in Schistosoma haematobium and S. mansoni infection  and has been proposed as a potential diagnostic plasma marker in Chagas' disease by using protein array mass spectrometry . Interestingly, fibronectin has been proposed to play a role in the extensive remodeling of the ECM during carcinogenesis  and has been found to be either up-regulated  or down-regulated  in different cancers. Given the progression of opisthorchiasis into CCA, it is of considerable interest to determine whether fibronectin plays a role in cholangiocarcinogenesis and whether this molecule could be utilized as a broad marker to follow the progression of CCA -beginning with infection, through advanced periductal fibrosis and finally carcinogenesis. Given the ubiquity of fibronectin in injury and disease the specificity of a marker based on this protein may not be high, but, in the context of an area of endemic O. viverrini infection, it could be useful at initial screening for possible infection and may provide a basis to detect the possibility of the onset of periductal fibrosis and ultimately CCA.
Secreted parasite antigens  stimulate the host response by the induction of inflammatory cell migration ,  and inflammatory cell responses to these antigens during inflammation. Alterations in the levels of signal transduction proteins is, therefore, likely to play a major role in host-parasite interaction in O. viverrini infection and may be exploited for early biomarker discovery ,  as well as potential therapeutic targets , . In our study, a number of protein expression changes associated with the host response to O. viverrini were identified in plasma for the first time. In particular changes in the expression levels of effector proteins such as PTPα, CLC-7 chloride channel protein, rhoGEF and PH domain containing 6, inversin, G protein-coupled receptor 153, and collapsin response mediator protein 1 were also identified. These proteins mediate a range of processes - for example, accumulation of CLC-7 chloride channel protein is associated with lysosomal pathology, osteopetrosis  and hepatocellular function . CLC-7 is also a potential therapeutic target for the treatment of osteoporosis . In general, signaling protein levels could be expected to increase early as a first response to parasite antigens (Figure 3) and for PTPα, this would appear to be the case. Using western blotting, this protein was first detected at day 21 and reached its peak expression one month post-infection (Figure 5A and 5B). Given the complexity of the host/parasite interactions, the identification of up-regulated proteins involved in gene expression and cellular control mechanisms not only provides a suite of potential early diagnostic markers but may also point the way to novel drug target for control of opisthorchiasis.
Signaling platforms that modulate the inflammatory response are new targets for drug development , and the PTP superfamily is a key regulatory component in many inflammatory pathways , . In this work, expression of PTPα was observed mainly in the cytoplasm of inflammatory cells of hamster livers infected with O. viverrini. The expression level of PTPα increased early in the host-parasite interaction, suggesting it is involved in the acute phase of O. viverrini infection. PTPα was also detected at increased levels in the plasma of opisthorchiasis patients and it was significantly decreased by drug treatment, suggesting circulating levels of the protein might be used as a diagnostic marker for opisthorchiasis. In protozoan parasites, host PTPα plays an important role in Leishmania donovani  and Trypanosoma brucei  infection, endemic in America and Africa. PTPα induction by Leishmania correlates with higher nitric oxide (NO) production . Relevantly, in O. viverrini-infected hamsters, we have demonstrated NO-mediated oxidative and nitrative DNA damage in a model of inflammation-mediated carcinogenesis . Overproduction of free radicals including NO and reactive oxygen species (ROS) may therefore participate in the induction of PTPα expression  at the early stage of O. viverrini infection.
We have identified several proteins involved in O. viverrini infection that might be associated with opisthorchiasis. Among these, fibronectin and PTPα may be useful in the diagnosis of O. viverrini infection. In addition, these 2 candidate proteins have been proposed to be useful as drug target treatment in other models. We therefore suggest that PTPα, at an early stage, and fibronectin, at the late stage, may be potential diagnostic markers and for novel drug target discovery of inflammation-mediated diseases including in O. viverrini infection in the future. Proteomics based analysis starting from animal to humans may assist in discovering biomarkers . Although the hamster genome has not been fully sequenced and short gun proteomic produced low Mascot Scoring , a hamster model of opisthorchiasis may provide a useful strategy to identify candidate markers applicable to human opisthorchiasis with potential utility for a novel diagnostic marker discovery.
We thank Prof. Visith Thongboonkerd, Faculty of Medicine Siriraj Hospital, Mahidol University for his advice and suggestion. We thank to the volunteers who donated their samples for this study. We also thank Miss Orapan Kingchaiyaphum, Research Assistant from Faculty of Medicine, Khon Kaen University, Thailand for a technician supporting. We wish to acknowledge the support of the Khon Kaen University Publication Clinic, Research and Technology Transfer Affairs, Khon Kaen University, for their assistance.
Conceived and designed the experiments: SP. Analyzed the data: JK UL CP. Contributed reagents/materials/analysis tools: SR PS. Wrote the paper: JK SP JM. Performed animal experiment, proteomic analysis, wesetern blot, immunohistrochemistry and statistic analysis: JK. Conducted double blinded check for western blot and immunohistochemistry analysis: UL. Consulted on proteomics work: SR. Re-analyzed bioinformatic work and peptide searching: PP. Provided a consult: CW PY CP. Performed ultrasonography on the patients: EM. Performed stool examination: PS. Performed all experiment and data analysis: SP.
- 1. Sripa B, Bethony JM, Sithithaworn P, Kaewkes S, Mairiang E, et al. (2011) Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos. Acta Trop 120 (Suppl 1) S158–168.
- 2. Kawanishi S, Hiraku Y, Pinlaor S, Ma N (2006) Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis. Biol Chem 387: 365–372.
- 3. Ohshima H, Bandaletova TY, Brouet I, Bartsch H, Kirby G, et al. (1994) Increased nitrosamine and nitrate biosynthesis mediated by nitric oxide synthase induced in hamsters infected with liver fluke (Opisthorchis viverrini). Carcinogenesis 15: 271–275.
- 4. Lankisch TO, Metzger J, Negm AA, Vobetakuhl K, Schiffer E, et al. (2011) Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis. Hepatology 53: 875–884.
- 5. Pinlaor S, Hiraku Y, Ma N, Yongvanit P, Semba R, et al. (2004) Mechanism of NO-mediated oxidative and nitrative DNA damage in hamsters infected with Opisthorchis viverrini: a model of inflammation-mediated carcinogenesis. Nitric Oxide 11: 175–183.
- 6. Mairiang E, Chaiyakum J, Chamadol N, Laopaiboon V, Srinakarin J, et al. (2006) Ultrasound screening for Opisthorchis viverrini-associated cholangiocarcinomas: experience in an endemic area. Asian Pac J Cancer Prev 7: 431–433.
- 7. Sripa B, Mairiang E, Thinkhamrop B, Laha T, Kaewkes S, et al. (2009) Advanced periductal fibrosis from infection with the carcinogenic human liver fluke Opisthorchis viverrini correlates with elevated levels of interleukin-6. Hepatology 50: 1273–1281.
- 8. Khoontawad J, Wongkham C, Hiraku Y, Yongvanit P, Prakobwong S, et al. (2010) Proteomic identification of peroxiredoxin 6 for host defence against Opisthorchis viverrini infection. Parasite Immunol 32: 314–323.
- 9. Prakobwong S, Yongvanit P, Hiraku Y, Pairojkul C, Sithithaworn P, et al. (2010) Involvement of MMP-9 in peribiliary fibrosis and cholangiocarcinogenesis via Rac1-dependent DNA damage in a hamster model. Int J Cancer 127: 2576–2587.
- 10. Thanan R, Murata M, Pinlaor S, Sithithaworn P, Khuntikeo N, et al. (2008) Urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine in patients with parasite infection and effect of antiparasitic drug in relation to cholangiocarcinogenesis. Cancer Epidemiol Biomarkers Prev 17: 518–524.
- 11. Dechakhamphu S, Yongvanit P, Nair J, Pinlaor S, Sitthithaworn P, et al. (2008) High excretion of etheno adducts in liver fluke-infected patients: protection by praziquantel against DNA damage. Cancer Epidemiol Biomarkers Prev 17: 1658–1664.
- 12. Anderson NL, Anderson NG (2002) The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 1: 845–867.
- 13. Prakobwong S, Pinlaor S, Yongvanit P, Sithithaworn P, Pairojkul C, et al. (2009) Time profiles of the expression of metalloproteinases, tissue inhibitors of metalloproteases, cytokines and collagens in hamsters infected with Opisthorchis viverrini with special reference to peribiliary fibrosis and liver injury. Int J Parasitol 39: 825–835.
- 14. de Roos B, Duthie SJ, Polley AC, Mulholland F, Bouwman FG, et al. (2008) Proteomic methodological recommendations for studies involving human plasma, platelets, and peripheral blood mononuclear cells. J Proteome Res 7: 2280–2290.
- 15. Omenn GS, States DJ, Adamski M, Blackwell TW, Menon R, et al. (2005) Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 5: 3226–3245.
- 16. Tammen H, Schulte I, Hess R, Menzel C, Kellmann M, et al. (2005) Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display. Proteomics 5: 3414–3422.
- 17. Haswell-Elkins MR, Mairiang E, Mairiang P, Chaiyakum J, Chamadol N, et al. (1994) Cross-sectional study of Opisthorchis viverrini infection and cholangiocarcinoma in communities within a high-risk area in northeast Thailand. Int J Cancer 59: 505–509.
- 18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275.
- 19. Thorsell A, Portelius E, Blennow K, Westman-Brinkmalm A (2007) Evaluation of sample fractionation using micro-scale liquid-phase isoelectric focusing on mass spectrometric identification and quantitation of proteins in a SILAC experiment. Rapid Commun Mass Spectrom 21: 771–778.
- 20. Charoensuk L, Pinlaor P, Prakobwong S, Hiraku Y, Laothong U, et al. (2011) Curcumin induces a nuclear factor-erythroid 2-related factor 2-driven response against oxidative and nitrative stress after praziquantel treatment in liver fluke-infected hamsters. Int J Parasitol 41: 615–626.
- 21. Tiberti N, Hainard A, Lejon V, Robin X, Ngoyi DM, et al. (2010) Discovery and verification of osteopontin and Beta-2-microglobulin as promising markers for staging human African trypanosomiasis. Mol Cell Proteomics 9: 2783–2795.
- 22. Norberg R, Thorstensson R, Utter G, Fagraeus A (1979) F-Actin-depolymerizing activity of human serum. Eur J Biochem 100: 575–583.
- 23. Kadler KE, Hill A, Canty-Laird EG (2008) Collagen fibrillogenesis: fibronectin, integrins, and minor collagens as organizers and nucleators. Curr Opin Cell Biol 20: 495–501.
- 24. Lucena S, Arocha Pinango CL, Guerrero B (2007) [Fibronectin. Structure and functions associated to hemostasis. Review]. Invest Clin 48: 249–262.
- 25. Simon K (1994) [The place of fibronectin in hepatologic diagnosis]. Wiad Lek 47: 854–858.
- 26. Aziz A, Zhang W, Li J, Loukas A, McManus DP, et al. (2011) Proteomic characterisation of Echinococcus granulosus hydatid cyst fluid from sheep, cattle and humans. J Proteomics 74: 1560–1572.
- 27. Al Adnani MS (1985) Concomitant immunohistochemical localization of fibronectin and collagen in schistosome granulomata. J Pathol 147: 77–85.
- 28. Ndao M, Spithill TW, Caffrey R, Li H, Podust VN, et al. (2010) Identification of novel diagnostic serum biomarkers for Chagas' disease in asymptomatic subjects by mass spectrometric profiling. J Clin Microbiol 48: 1139–1149.
- 29. Kaspar M, Zardi L, Neri D (2006) Fibronectin as target for tumor therapy. Int J Cancer 118: 1331–1339.
- 30. Ruiz-Garcia E, Scott V, Machavoine C, Bidart JM, Lacroix L, et al. (2010) Gene expression profiling identifies Fibronectin 1 and CXCL9 as candidate biomarkers for breast cancer screening. Br J Cancer 102: 462–468.
- 31. Gronborg M, Kristiansen TZ, Iwahori A, Chang R, Reddy R, et al. (2006) Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol Cell Proteomics 5: 157–171.
- 32. Mulvenna J, Sripa B, Brindley PJ, Gorman J, Jones MK, et al. (2010) The secreted and surface proteomes of the adult stage of the carcinogenic human liver fluke Opisthorchis viverrini. Proteomics 10: 1063–1078.
- 33. Sripa B, Kaewkes S (2000) Localisation of parasite antigens and inflammatory responses in experimental opisthorchiasis. Int J Parasitol 30: 735–740.
- 34. Hondermarck H, Vercoutter-Edouart AS, Revillion F, Lemoine J, el-Yazidi-Belkoura I, et al. (2001) Proteomics of breast cancer for marker discovery and signal pathway profiling. Proteomics 1: 1216–1232.
- 35. Srivastava G, Singh K, Tiwari MN, Singh MP (2010) Proteomics in Parkinson's disease: current trends, translational snags and future possibilities. Expert Rev Proteomics 7: 127–139.
- 36. Greggio E, Singleton A (2007) Kinase signaling pathways as potential targets in the treatment of Parkinson's disease. Expert Rev Proteomics 4: 783–792.
- 37. Hait WN, Hambley TW (2009) Targeted cancer therapeutics. Cancer Res 69: 1263–1267.
- 38. Weinert S, Jabs S, Supanchart C, Schweizer M, Gimber N, et al. (2010) Lysosomal pathology and osteopetrosis upon loss of H+−driven lysosomal Cl- accumulation. Science 328: 1401–1403.
- 39. Labat-Robert J (2002) Fibronectin in malignancy. Semin Cancer Biol 12: 187–195.
- 40. Zhao Q, Wei Q, He A, Jia R, Xiao Y (2009) CLC-7: a potential therapeutic target for the treatment of osteoporosis and neurodegeneration. Biochem Biophys Res Commun 384: 277–279.
- 41. McCulloch CA, Downey GP, El-Gabalawy H (2006) Signalling platforms that modulate the inflammatory response: new targets for drug development. Nat Rev Drug Discov 5: 864–876.
- 42. Tonks NK (2005) Redox redux: revisiting PTPs and the control of cell signaling. Cell 121: 667–670.
- 43. Zhang ZY (2003) Mechanistic studies on protein tyrosine phosphatases. Prog Nucleic Acid Res Mol Biol 73: 171–220.
- 44. Forget G, Gregory DJ, Whitcombe LA, Olivier M (2006) Role of host protein tyrosine phosphatase SHP-1 in Leishmania donovani-induced inhibition of nitric oxide production. Infect Immun 74: 6272–6279.
- 45. Szoor B, Wilson J, McElhinney H, Tabernero L, Matthews KR (2006) Protein tyrosine phosphatase TbPTP1: A molecular switch controlling life cycle differentiation in trypanosomes. J Cell Biol 175: 293–303.
- 46. Gomez MA, Li S, Tremblay ML, Olivier M (2007) NRAMP-1 expression modulates protein-tyrosine phosphatase activity in macrophages: impact on host cell signaling and functions. J Biol Chem 282: 36190–36198.
- 47. Shao C, Li M, Li X, Wei L, Zhu L, et al.. (2011) A tool for biomarker discovery in the urinary proteome: a manually curated human and animal urine protein biomarker database. Mol Cell Proteomics 10: M111 010975.
- 48. Cooper B (2011) The problem with peptide presumption and low Mascot scoring. J Proteome Res 10: 1432–1435.